GENERAL
Aurobindo Pharma To Acquire 80% Stake In A1 Biochem CRO Business
Aurobindo Pharma Ltd, through its wholly owned subsidiary Apitoria Pharma Pvt Ltd, will acquire an 80% stake in the Contract Research Services business of A1 Biochem Group. The acquisition will be completed within 90 to 120 days for cash consideration at an enterprise value of $17 million on a debt-free and cash-free basis. Building CRDMO […]
CW Bureau
·
Jul 24, 2026
STARTUP/TECHNOLOGY
NIT Rourkela Secures Patent For Eco-Friendly Film For Healthcare Products
Researchers at the National Institute of Technology (NIT) Rourkela have secured a patent for a biodegradable and antimicrobial bio-composite film that could replace petroleum-based plastic materials widely used in wound dressings, bandages and other healthcare products. The innovation, developed by researchers from the Department of Biotechnology and Medical Engineering, aims to tackle the growing challenge […]
CW Bureau
·
Jul 22, 2026
STARTUP/TECHNOLOGY
IITM, Herbalife Launch India’s First Plant Cell Fermentation Research CoE
Indian Institute of Technology Madras (IIT Madras), in collaboration with Herbalife International India Pvt Ltd, has inaugurated the Herbalife–IIT Madras Centre of Excellence (CoE) on Plant Cell Fermentation Technology, India’s first dedicated facility for translational research and innovation in plant cell fermentation. The initiative, launched on June 22, 2026, marks a significant step towards strengthening […]
CW Bureau
·
Jun 25, 2026
STARTUP/TECHNOLOGY
India Positions DeepTech Global: Modi And Macron Launch Bharat Innovates
Prime Minister Narendra Modi and French President Emmanuel Macron on Sunday jointly inaugurated the maiden edition of Bharat Innovates 2026 at the Palais des Expositions de Nice in France, marking a significant step in strengthening innovation-led collaboration between India and global stakeholders. Organised by the Government of India under the aegis of the Union Ministry […]
CW Bureau
·
Jun 14, 2026
GENERAL
Lupin Secures USFDA Approval For Ranibizumab Biosimilar Ranluspec
Global pharmaceutical major Lupin has received approval from the US Food and Drug Administration (FDA) for Ranluspec (ranibizumab-hkdz), an interchangeable biosimilar referencing Lucentis, marking a significant milestone in the company’s expanding biosimilars portfolio. The approval makes Ranluspec the only interchangeable ranibizumab biosimilar in the United States available in both vial and pre-filled syringe (PFS) presentations. […]
CW Bureau
·
Jun 5, 2026
STARTUP/TECHNOLOGY
Herbalife India And IITM Pact To Form Plant Cell Fermentation Technology
Herbalife International India Pvt Ltd has signed an agreement with Indian Institute of Technology Madras (IITM) to establish India’s first Plant Cell Fermentation Technology at the IITM Research Park called Herbalife–IIT Madras Centre of Excellence (CoE). The CoE, expected to commence operations from June 2026, aims to advance India’s capabilities in commercial plant cell fermentation […]
CW Bureau
·
Apr 17, 2026
